BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7665070)

  • 1. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
    Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
    Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon.
    Bourinbaiar AS; Lee-Huang S
    Biochem Biophys Res Commun; 1995 Mar; 208(2):779-85. PubMed ID: 7695636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
    Puri M; Kaur I; Kanwar RK; Gupta RC; Chauhan A; Kanwar JR
    Curr Mol Med; 2009 Dec; 9(9):1080-94. PubMed ID: 19747115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
    FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon.
    Fan JM; Zhang Q; Xu J; Zhu S; Ke T; Gao DF; Xu YB
    Mol Biol Rep; 2009 Feb; 36(2):381-8. PubMed ID: 18058255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
    Huang PL; Sun Y; Chen HC; Kung HF; Lee-Huang S
    Biochem Biophys Res Commun; 1999 Sep; 262(3):615-23. PubMed ID: 10471373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.
    Lee-Huang S; Kung HF; Huang PL; Bourinbaiar AS; Morell JL; Brown JH; Huang PL; Tsai WP; Chen AY; Huang HI
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12208-12. PubMed ID: 7527556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
    Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S
    Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
    Zhang LL; Ding Q; Zhan JB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
    Bourinbaiar AS; Lee-Huang S
    Biochem Biophys Res Commun; 1996 Feb; 219(3):923-9. PubMed ID: 8645280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
    Fan X; He L; Meng Y; Li G; Li L; Meng Y
    Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
    Schreiber CA; Wan L; Sun Y; Lu L; Krey LC; Lee-Huang S
    Fertil Steril; 1999 Oct; 72(4):686-90. PubMed ID: 10521111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
    Meng Y; Liu S; Li J; Meng Y; Zhao X
    Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
    Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ
    Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein.
    Moghadam A; Niazi A; Afsharifar A; Taghavi SM
    PLoS One; 2016; 11(7):e0159653. PubMed ID: 27459300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
    Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
    Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.
    Watts NR; Eren E; Palmer I; Huang PL; Huang PL; Shoemaker RH; Lee-Huang S; Wingfield PT
    PLoS One; 2023; 18(6):e0286370. PubMed ID: 37384752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.